Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Non-inferiority Trial of Placebo Versus Macrolide Antibiotics for Mycoplasma Pneumoniae Infection in Children With Community-acquired Pneumonia - the MYTHIC Study

NCT06325293 is registered in ClinicalTrials.gov with Christoph Berger as lead sponsor.

NCT NCT06325293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06325293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Non-inferiority Trial of Placebo Versus Macrolide Antibiotics for Mycoplasma Pneumoniae Infection in Children With Community-acquired Pneumonia - the MYTHIC Study
Lead sponsor
Christoph Berger
Phase
Not applicable
Overall status
Recruiting
Start date
January 28, 2025
Completion date
December 31, 2028
Enrollment
376 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

community acquired pneumonia in children, mycoplasma pneumoniae, mycoplasma pneumoniae pneumonia